HCWC CEO awarded 98,186 restricted shares

HEALTHY CHOICE WELLNESS CORP. chief executive officer Jeffrey Elliot Holman reported a compensation-related equity award.

Rhea-AI Filing Summary

HEALTHY CHOICE WELLNESS CORP. chief executive officer Jeffrey Elliot Holman reported a compensation-related equity award. On May 25, 2026, he acquired 98,186 shares of Class A Common Stock through a restricted stock award vesting on that date, at a stated price of $0.00 per share.

After this vesting event, he directly holds 1,377,598 shares of common stock. Footnotes also describe additional unvested, time-based restricted stock awards totaling hundreds of thousands of shares that vest in scheduled quarterly installments and may fully vest upon certain change of control events.

Insider Trade Summary

Grant/Award: 98,186 shares

Grant/Award 1 txn

Insider Holman Jeffrey Elliot

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	98,186	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 1,377,598 shares (Direct)

Footnotes (2)

1. F1. Restricted Stock award of 98,186 vested on May 25, 2026.
2. F2. Registrant's holdings include (a) 1,377,598 shares of common stock held directly, (b) 600,000 unvested shares of restricted common stock granted on November 12, 2025, which is a time-based restricted stock award that vests in six quarterly installments of 100,000 shares with next vesting on August 12, 2026, and (c) 687,301 unvested shares of restricted common stock granted on February 25, 2026, which is a time-based restricted stock award that vests in eight equal quarterly installments of 98,186 shares with next vesting on August 25, 2026. The Restricted Stock will immediately vest upon the occurrence of certain change of control events set forth in the Reporting Person's Restricted Stock Award Agreements.

Key Figures

Restricted stock vested: 98,186 shares Price per vested share: $0.00 per share Direct holdings after transaction: 1,377,598 shares +4 more

7 metrics

Restricted stock vested 98,186 shares Class A Common Stock vested on May 25, 2026

Price per vested share $0.00 per share Reported transaction price for restricted stock vesting

Direct holdings after transaction 1,377,598 shares Common stock held directly following May 25, 2026 vesting

Unvested award 1 600,000 shares Restricted stock granted November 12, 2025, time-based

Unvested award 2 687,301 shares Restricted stock granted February 25, 2026, time-based

Next vesting date award 1 August 12, 2026 Next quarterly installment for 600,000-share award

Next vesting date award 2 August 25, 2026 Next quarterly installment for 687,301-share award

Key Terms

Restricted Stock, time-based restricted stock award, change of control events, Class A Common Stock

4 terms

Restricted Stock financial

"Restricted Stock award of 98,186 vested on May 25, 2026."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

time-based restricted stock award financial

"which is a time-based restricted stock award that vests in six quarterly installments"

change of control events financial

"The Restricted Stock will immediately vest upon the occurrence of certain change of control events"

Class A Common Stock financial

"security_title": "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HCWC CEO Jeffrey Holman report?

HCWC CEO Jeffrey Holman reported acquiring 98,186 shares of Class A Common Stock on May 25, 2026, as a restricted stock award that vested that day, reflecting compensation rather than an open-market stock purchase or sale.

How many HCWC shares does the CEO hold after this Form 4 transaction?

Following the May 25, 2026 vesting, the CEO directly holds 1,377,598 shares of Healthy Choice Wellness Corp. common stock, according to the Form 4, in addition to separate unvested restricted stock awards described in the footnotes.

Was the HCWC CEO’s Form 4 transaction a market purchase or sale?

The Form 4 transaction was a grant and vesting of restricted stock, not an open-market purchase or sale. The 98,186 shares of Class A Common Stock vested as part of a compensation award with a reported price of $0.00 per share.

What unvested restricted stock awards does the HCWC CEO hold?

Footnotes state the CEO has 600,000 unvested restricted shares granted November 12, 2025 and 687,301 unvested restricted shares granted February 25, 2026, both time-based awards that vest in scheduled quarterly installments over future dates.

When are the next vesting dates for the HCWC CEO’s restricted stock?

The next vesting for the 600,000-share award is August 12, 2026, and the next vesting for the 687,301-share award is August 25, 2026, with both awards vesting in equal quarterly installments over their respective schedules.

Can the HCWC CEO’s restricted stock vest sooner than scheduled?

Yes. Footnotes explain the restricted stock will immediately vest upon the occurrence of certain change of control events specified in the CEO’s Restricted Stock Award Agreements, which would accelerate vesting outside the normal quarterly schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/27/2026 - 09:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Holman Jeffrey Elliot

(Last) (First) (Middle)

3800 NORTH 28TH WAY, UNIT 1

(Street)

HOLLYWOOD FLORIDA 33020

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHY CHOICE WELLNESS CORP. [ HCWC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	05/25/2026		A		98,186(1)	A	$0.00	1,377,598(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock award of 98,186 vested on May 25, 2026.

2. Registrant's holdings include (a) 1,377,598 shares of common stock held directly, (b) 600,000 unvested shares of restricted common stock granted on November 12, 2025, which is a time-based restricted stock award that vests in six quarterly installments of 100,000 shares with next vesting on August 12, 2026, and (c) 687,301 unvested shares of restricted common stock granted on February 25, 2026, which is a time-based restricted stock award that vests in eight equal quarterly installments of 98,186 shares with next vesting on August 25, 2026. The Restricted Stock will immediately vest upon the occurrence of certain change of control events set forth in the Reporting Person's Restricted Stock Award Agreements.

	/s/ Martin Schrier, as Attorney-in-Fact for Jeffrey Elliot Holman	05/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)